JP2009296914A - Cardiopulmonary function-improving composition - Google Patents

Cardiopulmonary function-improving composition Download PDF

Info

Publication number
JP2009296914A
JP2009296914A JP2008153283A JP2008153283A JP2009296914A JP 2009296914 A JP2009296914 A JP 2009296914A JP 2008153283 A JP2008153283 A JP 2008153283A JP 2008153283 A JP2008153283 A JP 2008153283A JP 2009296914 A JP2009296914 A JP 2009296914A
Authority
JP
Japan
Prior art keywords
cardiopulmonary function
egg white
composition
exercise
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008153283A
Other languages
Japanese (ja)
Inventor
Minako Suga
美奈子 菅
Yuichiro Horii
悠一郎 堀井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharma Foods International Co Ltd
Original Assignee
Pharma Foods International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Foods International Co Ltd filed Critical Pharma Foods International Co Ltd
Priority to JP2008153283A priority Critical patent/JP2009296914A/en
Publication of JP2009296914A publication Critical patent/JP2009296914A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a cardiopulonary function-improving composition which is safe even when taken for a long period of time, improves cardiopulmonary function in a short time by oral intake before exercise, and holds promise in exercise performance-improving effect. <P>SOLUTION: The cardiopulmonary function-improving composition contains an egg albumen hydrolysate and organic acid as its active ingredients. The cardiopulmonary function-improving composition preferably contains 0.2-1.2 pts.mass of the organic acid based on 1 pt.mass of the egg albumen hydrolysate (solid). The organic acid preferably is citric acid. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、心肺機能の向上効果が期待できる組成物に関する。   The present invention relates to a composition that can be expected to improve cardiopulmonary function.

運動終了後の心拍数が安定時の心拍数に近づく心拍を回復心拍数といい、運動終了5分後の心拍数が120拍/分以上の場合は、その時の身体状態に対して運動が強すぎると言われている。日頃からトレーニングを行っている人は、この心拍数の回復が早くなることが知られており、結果として高い運動強度にも適応できるようになる。例えば、多くのスポーツにおいては、競技時間中に短いインターバルが設けられているが、そのインターバルの間にどれだけ疲労回復できるかが勝敗を左右することにもなるため、心拍数を速やかに回復させることは有意義であると考えられる。   The heart rate that is close to the heart rate at the end of exercise is called the recovery heart rate. If the heart rate is 120 beats / minute or more 5 minutes after the end of exercise, exercise is strong against the physical condition at that time. It is said that it is too much. People who are training regularly are known to recover this heart rate faster, and as a result, they can adapt to high exercise intensity. For example, in many sports, there is a short interval during the competition time, but how much fatigue can be recovered during that interval also determines the victory or defeat, so the heart rate is recovered quickly. This is considered significant.

一般的に、運動におけるパフォーマンスの低下は、疲労物質の蓄積、エネルギー源の不足、発汗による水分やミネラル分の消失などにより引き起こされると言われている。そのため、疲労物質の低減、エネルギー源となる糖質やビタミン類、水分やミネラル分の補給などを目的とした飲食品が数多く開発されている。   In general, it is said that the decrease in performance during exercise is caused by accumulation of fatigue substances, lack of energy sources, loss of moisture and minerals due to sweating, and the like. Therefore, many foods and drinks have been developed for the purpose of reducing fatigue substances, supplementing sugars and vitamins, which are energy sources, and moisture and minerals.

例えば、特許文献1には、所定量のクエン酸を添加したスポーツ用飲料について開示されており、クエン酸の効果によって乳酸値を低下させ、疲労回復を促進させることができる旨記載されている。   For example, Patent Document 1 discloses a sports beverage to which a predetermined amount of citric acid is added, and describes that the effect of citric acid can reduce the lactic acid level and promote fatigue recovery.

また、本出願人は、卵白ペプチドが血中乳酸値の上昇抑制効果や深部体温の上昇抑制効を有することを見出し、特許文献2において、卵白を加水分解して得られる卵白ペプチドを有効成分として含有することを特徴とする血中乳酸値上昇抑制組成物について開示しており、特許文献3において、卵白を加水分解して得られる卵白ペプチドを有効成分として含有することを特徴とする熱中症予防飲料について開示している。
特開2006−42602号公報 特開2006−273850号公報 特開2008−72968号公報
In addition, the present applicant has found that egg white peptides have an inhibitory effect on the increase in blood lactic acid level and an inhibitory effect on the increase in deep body temperature. In Patent Document 2, an egg white peptide obtained by hydrolyzing egg white is used as an active ingredient. Disclosed is a composition for suppressing an increase in blood lactic acid level, characterized by containing, and in Patent Document 3, containing egg white peptide obtained by hydrolyzing egg white as an active ingredient The beverage is disclosed.
JP 2006-42602 A JP 2006-273850 A JP 2008-72968 A

しかし、上述したような従来の飲食品の多くは、対処療法的に用いられるものであり、運動パフォーマンスの向上というよりも、運動パフォーマンスの維持を目的とするものであった。   However, many of the conventional foods and drinks as described above are used for coping therapy, and are aimed at maintaining exercise performance rather than improving exercise performance.

一方、心肺機能の向上は、運動パフォーマンスの向上につながるが、日常的なトレーニングを積むことで初めて得られるものであり、通常、短期間のうちに心肺機能を向上させることは困難である。   On the other hand, the improvement of the cardiopulmonary function leads to the improvement of the exercise performance, but it can be obtained only by daily training, and it is usually difficult to improve the cardiopulmonary function within a short period of time.

したがって、本発明の目的は、長期間服用しても安全で、運動前に経口摂取することにより、短時間で心肺機能を向上させることができ、運動パフォーマンス向上が期待できる組成物を提供することにある。   Therefore, an object of the present invention is to provide a composition that can be safely taken for a long period of time and can improve cardiopulmonary function in a short time by taking it orally before exercise, and can be expected to improve exercise performance. It is in.

すなわち、本発明の心肺機能向上用組成物は、卵白加水分解物と有機酸を有効成分として含有することを特徴とする。   That is, the composition for improving cardiopulmonary function of the present invention is characterized by containing an egg white hydrolyzate and an organic acid as active ingredients.

本発明の心肺機能向上用組成物においては、卵白加水分解物(固形分)1質量部に対して、有機酸を0.2〜1.2質量部含有することが好ましく、前記有機酸はクエン酸であることが好ましい。   In the composition for improving cardiopulmonary function of the present invention, the organic acid is preferably contained in an amount of 0.2 to 1.2 parts by mass with respect to 1 part by mass of the egg white hydrolyzate (solid content), and the organic acid is citric acid. Is preferred.

本発明の心肺機能向上用組成物は、卵白加水分解物と有機酸との相乗効果により、心肺機能を向上させ、運動後の心拍数の回復を早めることができる。その結果、競技時間中の短いインターバルの間にも疲労の回復が可能となり、運動パフォーマンスの向上が期待できる。   The composition for improving cardiopulmonary function of the present invention can improve cardiopulmonary function and accelerate recovery of heart rate after exercise by the synergistic effect of egg white hydrolyzate and organic acid. As a result, it is possible to recover from fatigue even during a short interval during the competition time, and an improvement in exercise performance can be expected.

本発明によれば、経口摂取することにより、心肺機能を向上させ、運動後の心拍数の回復を早め、運動パフォーマンスの向上が期待できる組成物を提供できる。本組成物の有効成分である卵白や有機酸は古くから食経験のある安全な素材であるので、副作用の心配がなく、継続的に摂取することができる。   According to the present invention, it is possible to provide a composition that can be expected to improve exercise performance by improving cardiopulmonary function, speeding up recovery of heart rate after exercise, and taking exercise orally. Egg whites and organic acids, which are the active ingredients of this composition, are safe ingredients that have been eaten for a long time, so there is no concern about side effects and they can be taken continuously.

以下、本発明の心肺機能向上用組成物の原料について説明する。   Hereinafter, the raw material of the composition for improving cardiopulmonary function of the present invention will be described.

本発明において、有効成分として用いられる卵白加水分解物は、卵白を酸や酵素を用いて加水分解して得られる卵白ペプチド組成物であり、好ましくは卵白を酵素分解して得られるものが用いられる。   In the present invention, the egg white hydrolyzate used as an active ingredient is an egg white peptide composition obtained by hydrolyzing egg white using an acid or an enzyme, and preferably obtained by enzymatic decomposition of egg white. .

原料卵白は、例えば、ニワトリ、ウズラ、アヒル、ガチョウ等の卵の卵白が挙げられるが、大量入手が容易な鶏卵の卵白が好ましく、卵白液、凍結卵白液、卵白粉末等を用いることができ、特に脱糖処理したものが好ましく用いられる。   The raw egg white is, for example, egg white of chicken, quail, duck, goose, etc., but egg white of chicken eggs that are easily available in large quantities is preferred, egg white liquid, frozen egg white liquid, egg white powder, etc. can be used, In particular, those subjected to desugaring treatment are preferably used.

卵白加水分解物は、例えば、液卵白1質量部に水0.1〜1質量部を加えて撹拌したものに加水分解酵素を添加して酵素反応を所定時間行った後、酵素失活処理し、固液分離して液部を回収し、乾燥粉末化することにより得ることができる。なお、必要に応じて、限外濾過膜、逆浸透膜、ゲル濾過や各種カラムクロマトグラフィー、メンブレンフィルター等を用いて分画、精製してもよい。   For example, the egg white hydrolyzate is prepared by adding hydrolase to 1 part by weight of liquid egg white and adding 0.1 to 1 part by weight of water and stirring the enzyme, followed by an enzyme reaction for a predetermined time, and then subjecting the enzyme to inactivation. It can be obtained by separating the liquid and recovering the liquid part and making it into dry powder. If necessary, fractionation and purification may be performed using an ultrafiltration membrane, a reverse osmosis membrane, gel filtration, various column chromatography, a membrane filter, or the like.

加水分解酵素としては、プロテアーゼ活性又はペプチダーゼ活性を有し、食品製造に使用可能なタンパク質加水分解酵素が用いられ、具体的には、パパイン(EC.3.4.22.2)、トリプシン(EC.3.4.21.4)、バチルス属細菌由来プロテアーゼ(例えば、商品名「プロテアーゼS「アマノ」G」、商品名「プロテアーゼN「アマノ」G」、商品名「プロレザーFG−F」(いずれも天野エンザイム株式会社製))、リゾプス属糸状菌由来ペプチダーゼ(例えば、商品名「ペプチダーゼR」(天野エンザイム株式会社製))等を組み合わせて用いることが好ましい。タンパク質加水分解酵素の使用量や反応温度、反応時間等は、使用する酵素に応じて適宜調整すればよい。   As the hydrolase, a protein hydrolase having protease activity or peptidase activity and usable for food production is used. Specifically, papain (EC.3.4.22.2), trypsin (EC.3.4.21.4 ), Protease derived from Bacillus bacteria (for example, trade name “Protease S“ Amano ”G”, trade name “Protease N“ Amano ”G”, trade name “Pro Leather FG-F” (all manufactured by Amano Enzyme, Inc.) ), A peptidase derived from Rhizopus fungi (for example, trade name “peptidase R” (manufactured by Amano Enzyme Inc.)) and the like are preferably used in combination. What is necessary is just to adjust suitably the usage-amount of protein hydrolase, reaction temperature, reaction time, etc. according to the enzyme to be used.

本発明において、もう一つの有効成分として用いられる有機酸は、飲食品に利用可能なものであればよく、具体的には、クエン酸、リンゴ酸、酢酸などが例示できる。本発明においては、クエン酸が特に好ましく用いられる。   In this invention, the organic acid used as another active ingredient should just be a thing usable for food-drinks, Specifically, a citric acid, malic acid, an acetic acid etc. can be illustrated. In the present invention, citric acid is particularly preferably used.

本発明の組成物における卵白加水分解物と有機酸の配合割合は、卵白加水分解物(固形分)1質量部に対して、有機酸0.2〜1.2質量部であり、好ましくは卵白加水分解物(固形分)1質量部に対して、有機酸0.4〜1質量部である。   The blending ratio of the egg white hydrolyzate and the organic acid in the composition of the present invention is 0.2 to 1.2 parts by mass of the organic acid with respect to 1 part by mass of the egg white hydrolyzate (solid content), preferably the egg white hydrolyzate ( The solid content is 0.4 to 1 part by mass of organic acid with respect to 1 part by mass.

本発明の組成物は、そのままサプリメントなどとして用いることもできるが、スポーツ飲料やゼリー飲料、栄養・エネルギーバーをはじめとする各種飲食品に配合することができる。   The composition of the present invention can be used as a supplement as it is, but can be blended in various foods and drinks including sports drinks, jelly drinks, and nutrition / energy bars.

本発明の組成物を、運動前に500mg〜10g、好ましくは1g〜5g摂取することにより、心肺機能向上効果が期待できる。したがって、上記飲食品における本組成物の添加量も、1食分あたり上記の量が摂取できるように設定することが好ましい。   By taking 500 mg to 10 g, preferably 1 g to 5 g of the composition of the present invention before exercise, an effect of improving cardiopulmonary function can be expected. Therefore, it is preferable to set the addition amount of the present composition in the food and drink so that the above amount can be ingested per serving.

本発明の組成物は、上記基本的成分のほかに、賦形剤、乳化剤、安定剤、甘味料、pH調整剤、増粘剤、香料、酸味料等の食品添加剤や、ビタミン類、ミネラル類、分枝鎖アミノ酸(バリン、ロイシン、イソロイシン)、アンセリン、カルノシン、カルニチン、クレアチン、γ−アミノ酪酸等の生理活性成分を含むこともできる。   In addition to the above basic components, the composition of the present invention includes food additives such as excipients, emulsifiers, stabilizers, sweeteners, pH adjusters, thickeners, fragrances, acidulants, vitamins, minerals And physiologically active components such as branched chain amino acids (valine, leucine, isoleucine), anserine, carnosine, carnitine, creatine, and γ-aminobutyric acid.

以下、実施例を挙げて本発明を具体的に説明するが、本発明はこれによって特に限定されるものではない。また、特に断りのない限り、「%」は「質量%」を表す。   Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not particularly limited thereto. Unless otherwise specified, “%” represents “% by mass”.

液卵白12kg(固形分12.5%)を常法に従って脱糖処理(酵母発酵法)を行った後、水3.7Lを加えて均一に撹拌した。この卵白溶液の液温を60℃に調整し、以下の順序で酵素反応を行った。   After 12 kg of liquid egg white (solid content 12.5%) was subjected to a desugaring treatment (yeast fermentation method) according to a conventional method, 3.7 L of water was added and stirred uniformly. The temperature of the egg white solution was adjusted to 60 ° C., and the enzyme reaction was performed in the following order.

1)パパイン(商品名「パパイン300」、日本バイオコン株式会社製)30gを添加して1.5時間反応。   1) 30 g of papain (trade name “Papain 300”, manufactured by Nippon Biocon Co., Ltd.) was added and reacted for 1.5 hours.

2)水酸化ナトリウムでpH調整(pH8.0)し、トリプシン5gを添加して55℃で1時間反応。   2) Adjust pH with sodium hydroxide (pH 8.0), add 5g of trypsin, and react at 55 ° C for 1 hour.

3)バチルス属細菌由来プロテアーゼ(商品名「プロテアーゼS「アマノ」G」、天野エンザイム株式会社製)15gを添加して65℃で1時間反応。   3) Bacillus genus-derived protease (trade name “Protease S“ Amano ”G”, Amano Enzyme Co., Ltd.) 15 g was added and reacted at 65 ° C. for 1 hour.

4)バチルス属細菌由来プロテアーゼ(商品名「プロテアーゼN「アマノ」G」、天野エンザイム株式会社製)10gを添加して55℃で1時間反応。   4) 10 g of protease derived from Bacillus genus (trade name “Protease N“ Amano ”G, manufactured by Amano Enzyme Co., Ltd.) was added and reacted at 55 ° C. for 1 hour.

5)リゾプス属糸状菌由来ペプチダーゼ(商品名「ペプチダーゼR」、天野エンザイム株式会社製)5gを添加して40℃で4時間反応。   5) Add 5 g of Rhizopus fungi-derived peptidase (trade name “Peptidase R”, manufactured by Amano Enzyme) and react at 40 ° C. for 4 hours.

上記酵素反応終了後、90℃で10分間加熱した後、濾過し、得られた濾液を噴霧乾燥して900gの卵白加水分解物(サンプル1)を得た。   After completion of the enzyme reaction, the mixture was heated at 90 ° C. for 10 minutes, filtered, and the obtained filtrate was spray-dried to obtain 900 g of egg white hydrolyzate (sample 1).

得られた卵白加水分解物を高速液体クロマトグラフィーにて、以下の条件で分子量の分析を行った。その結果を図1に示す。   The obtained egg white hydrolyzate was analyzed for molecular weight by high performance liquid chromatography under the following conditions. The result is shown in FIG.

カラム:「YMC-Pack Dio1-60(8.0×500mm)」(商品名、株式会社ワイエムシイ製)
溶出液:0.1Mリン酸カリウム緩衝液(pH7.0)
流速:0.7mL/分
検出波長:215nm
Column: “YMC-Pack Dio1-60 (8.0 × 500mm)” (trade name, manufactured by YMC Corporation)
Eluent: 0.1M potassium phosphate buffer (pH 7.0)
Flow rate: 0.7mL / min Detection wavelength: 215nm

そして、上記卵白加水分解物を適量の水に溶解し、卵白加水分解物(固形分)1質量部に対し、クエン酸(無水)1質量部を添加して均一に溶解した後、凍結乾燥して、本発明の心肺機能向上用組成物(サンプル2)を得た。   Then, the above egg white hydrolyzate is dissolved in a suitable amount of water, and 1 part by weight of citric acid (anhydrous) is added to 1 part by weight of the egg white hydrolyzate (solid content), and then uniformly lyophilized. Thus, the composition for improving cardiopulmonary function of the present invention (Sample 2) was obtained.

また、同様にして卵白加水分解物(固形分)1質量部に対し、クエン酸(無水)0.4質量部を添加して本発明の心肺機能向上用組成物(サンプル3)を調製した。
(試験例)
Similarly, 0.4 part by mass of citric acid (anhydrous) was added to 1 part by mass of the egg white hydrolyzate (solid content) to prepare the composition for improving cardiopulmonary function (Sample 3) of the present invention.
(Test example)

上記で得られたサンプルを用いて運動負荷試験を行った。
i)群分け及び被験者
コントロール群:水100mL
比較群:卵白加水分解物(サンプル1)0.5%水溶液100mL
試験群:心肺機能向上用組成物(サンプル2)1%水溶液100mL
An exercise load test was performed using the sample obtained above.
i) Grouping and subjects Control group: 100 mL water
Comparative group: Egg white hydrolyzate (Sample 1) 0.5% aqueous solution 100mL
Test group: Composition for improving cardiopulmonary function (Sample 2) 1% aqueous solution 100mL

各群6名(男性3名、女性3名(平均年齢26.3±1.8歳))とし、各群の試験は1週間の間隔を空けて行った。   Each group consisted of 6 people (3 males and 3 females (mean age 26.3 ± 1.8 years)), and each group was tested at 1 week intervals.

ii)試験方法
図2に示すプロトコールで、自転車運動装置を用いて、60%VO2maxの運動強度で運動負荷試験を行った。そして、運動負荷試験中、被験者の心拍数をモニターし、運動負荷試験終了時から心拍数が100拍/分になるまでの時間を計測し、心拍数回復時間とした。各群における心拍数回復時間を比較した結果を図3に示す。
ii) Test method An exercise load test was conducted with a exercise intensity of 60% VO2max using a bicycle exercise apparatus according to the protocol shown in FIG. Then, during the exercise test, the subject's heart rate was monitored, and the time from the end of the exercise test until the heart rate reached 100 beats / minute was measured to obtain the heart rate recovery time. The result of comparing the heart rate recovery time in each group is shown in FIG.

図3から、コントロール群と比べて、比較群(サンプル1)及び試験群(サンプル2)では、運動負荷試験後の心拍数回復時間が短縮されていることが分かる。特に試験群(サンプル2)においては、コントロール群に比べて約2/3に短縮されていることが分かる。なお、サンプル3を用いても上記試験群(サンプル2)と同程度の心拍数回復時間の短縮が見られた。   FIG. 3 shows that the heart rate recovery time after the exercise stress test is shortened in the comparison group (sample 1) and the test group (sample 2) compared to the control group. In particular, it can be seen that the test group (sample 2) is shortened to about 2/3 compared to the control group. In addition, even when Sample 3 was used, the heart rate recovery time was reduced as much as in the above test group (Sample 2).

以上の結果から、本発明の心肺機能向上用組成物を摂取することにより、心肺機能をより高めることができ、結果として運動パフォーマンスの向上が期待できる。   From the above results, by ingesting the cardiopulmonary function improving composition of the present invention, the cardiopulmonary function can be further enhanced, and as a result, improvement in exercise performance can be expected.

本発明の心肺機能向上用組成物は、アスリートだけでなく、メタボリック対策で運動を始める人などに好適に利用できる。   The composition for improving the cardiopulmonary function of the present invention can be suitably used not only for athletes but also for people who start exercising with metabolic measures.

得られた卵白加水分解物のゲル濾過クロマトグラフィーの結果を示した図である。It is the figure which showed the result of the gel filtration chromatography of the obtained egg white hydrolyzate. 自転車運動装置を用いたヒト試験のプロトコールを示した図である。It is the figure which showed the protocol of the human test using a bicycle exercise apparatus. 運動負荷試験後の心拍数回復時間を測定した結果を示した図である。It is the figure which showed the result of having measured the heart rate recovery time after the exercise load test.

Claims (4)

卵白加水分解物と有機酸を有効成分として含有することを特徴とする心肺機能向上用組成物。   A composition for improving cardiopulmonary function, comprising an egg white hydrolyzate and an organic acid as active ingredients. 卵白加水分解物(固形分)1質量部に対して、有機酸を0.2〜1.2質量部含有する請求項1記載の心肺機能向上用組成物。   The composition for improving cardiopulmonary function according to claim 1, comprising 0.2 to 1.2 parts by mass of an organic acid per 1 part by mass of the egg white hydrolyzate (solid content). 前記有機酸はクエン酸である請求項1又は2記載の心肺機能向上用組成物。   The composition for improving cardiopulmonary function according to claim 1 or 2, wherein the organic acid is citric acid. 請求項1〜3のいずれか一つに記載の心肺機能向上用組成物を含有する飲食品。   Food-drinks containing the composition for cardiopulmonary function improvement as described in any one of Claims 1-3.
JP2008153283A 2008-06-11 2008-06-11 Cardiopulmonary function-improving composition Pending JP2009296914A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008153283A JP2009296914A (en) 2008-06-11 2008-06-11 Cardiopulmonary function-improving composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008153283A JP2009296914A (en) 2008-06-11 2008-06-11 Cardiopulmonary function-improving composition

Publications (1)

Publication Number Publication Date
JP2009296914A true JP2009296914A (en) 2009-12-24

Family

ID=41544484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008153283A Pending JP2009296914A (en) 2008-06-11 2008-06-11 Cardiopulmonary function-improving composition

Country Status (1)

Country Link
JP (1) JP2009296914A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011173817A (en) * 2010-02-23 2011-09-08 Pharma Foods International Co Ltd Nitrogen monoxide production-promoting composition and male function improver containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011173817A (en) * 2010-02-23 2011-09-08 Pharma Foods International Co Ltd Nitrogen monoxide production-promoting composition and male function improver containing the same

Similar Documents

Publication Publication Date Title
US9993515B2 (en) Methods of treatment using water-soluble tryptophan-containing peptides obtained by the hydrolysis of hens eggs lysozyme
KR101698216B1 (en) Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
US7977066B2 (en) Method for preparing tryptophan rich peptides
US20100087359A1 (en) Use of tryptophan rich peptides
JP2006273850A (en) Suppression composition for lactic acid value elevation in blood, and food and drink comprising same
US20100286034A1 (en) Uses for aqueous streams containing proteins
JP2007051090A (en) Blood flow improving agent containing egg white peptide as active ingredient
JP7428480B2 (en) Compositions for improving sleep and foods, medicines, and feed containing the compositions
JP2009296914A (en) Cardiopulmonary function-improving composition
JP2008072968A (en) Drink for preventing heat stroke
CA2944413C (en) Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase
JP2007151427A (en) Albumen hydrolyzate richly containing cysteine, and food and drink containing the same
JP2019041696A (en) Oral composition
Hsu et al. Hydrolysates from tuna cooking juice as an anti-hypertensive agent
JP2019054769A (en) Food for hair graying suppression
JPH0322371B2 (en)
AU2008200050A1 (en) Method For Preparing Tryptophan Rich Peptides
NZ526083A (en) Method for preparing tryptophan rich peptides